Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 352 entries
View as:

Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT00507065 Org: User:
Start: 05/28/03 End: 03/24/04 Due: 03/24/05

A Study of Anagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia Patients

Phase: N/A Priority: Normal
NCT ID: NCT00202644 Org: User:
Start: 01/13/06 End: 12/15/15 Due: 12/15/16

Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT01244490 Org: User:
Start: 01/17/11 End: 05/01/13 Due: 05/01/14

Drug Use Study With Intuniv® in European Countries

Phase: N/A Priority: Normal
NCT ID: NCT05870605 Org: User:
Start: 11/15/18 End: 04/30/22 Due: 04/30/23

Safety and Efficacy Study of Several Replagal Dosing Regimens on Cardiac Function in Adults With Fabry Disease

Phase: N/A Priority: Normal
NCT ID: NCT00864851 Org: User:
Start: 12/29/08 End: 07/05/12 Due: 07/05/13

Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)

Phase: N/A Priority: Normal
NCT ID: NCT00457015 Org: User:
Start: 04/01/07 End: 06/01/08 Due: 06/01/09

Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric ENT Surgery (The HATT Project)

Phase: N/A Priority: Normal
NCT ID: NCT02095015 Org: User:
Start: 05/21/14 End: 08/14/15 Due: 08/14/16

FST-100 in the Treatment of Acute Viral Conjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT01461954 Org: User:
Start: 05/17/13 End: 03/10/14 Due: 03/10/15

A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT00500149 Org: User:
Start: 06/13/07 End: 12/05/07 Due: 12/05/08

Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00798967 Org: User:
Start: 11/25/08 End: 01/25/11 Due: 01/25/12

Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)

Phase: N/A Priority: Normal
NCT ID: NCT00633139 Org: User:
Start: 01/22/07 End: 11/25/08 Due: 11/25/09

The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET)

Phase: N/A Priority: Normal
NCT ID: NCT00413634 Org: User:
Start: 11/13/06 End: 01/22/08 Due: 01/22/09

Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT00697515 Org: User:
Start: 07/18/08 End: 12/20/08 Due: 12/20/09

Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00503243 Org: User:
Start: 09/30/03 End: 01/17/05 Due: 01/17/06

A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants

Phase: N/A Priority: Normal
NCT ID: NCT02927067 Org: User:
Start: 04/14/17 End: 07/01/22 Due: 07/01/23

Gaucher Disease Outcome Survey (GOS)

Phase: N/A Priority: Normal
NCT ID: NCT03291223 Org: User:
Start: 07/27/10 End: 09/30/25 Due: 09/30/26

Efficacy and Safety of SPD503 in Combination With Psychostimulants

Phase: N/A Priority: Normal
NCT ID: NCT00734578 Org: User:
Start: 09/02/08 End: 12/10/09 Due: 12/10/10

Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00012259 Org: User:
Start: 12/11/00 End: 03/27/02 Due: 03/27/03

Taste Assessment Study of SHP429 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02125292 Org: User:
Start: 06/02/14 End: 06/19/14 Due: 06/19/15

Dynepo Long-Term Safety Study

Phase: N/A Priority: Normal
NCT ID: NCT00514813 Org: User:
Start: 06/06/07 End: 07/31/08 Due: 07/31/09

Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)

Phase: N/A Priority: Normal
NCT ID: NCT02340819 Org: User:
Start: 12/18/14 End: 11/05/18 Due: 11/05/19

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT03259334 Org: User:
Start: 02/09/18 End: 10/23/20 Due: 10/23/21

Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00432510 Org: User:
Start: 10/09/06 End: 02/28/07 Due: 02/28/08

An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients

Phase: N/A Priority: Normal
NCT ID: NCT00882921 Org: User:
Start: 10/14/08 End: 02/08/13 Due: 02/08/14

Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02402166 Org: User:
Start: 04/15/15 End: 06/30/16 Due: 06/30/17